BR
BrainsWay Ltd.
BRSYF · OTC
$13.55 -10.44% (-$1.58)
Market Cap $543.8M
P/E Ratio 57.34x
Div. Yield -
ROE 12.71%
Bulios Fair Price
$13.27
2.1% downside
Trenutna cena
$13.55
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price se delnica BRSYF trenutno trguje blizu svoje poštene vrednosti. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
6/9Valuation
11 /100
Expensive P/E 57.34x
PEG 0.36x
EV/EBITDA 42.31x
Growth
100 /100
Growing Rev. growth 27.65%
Book val. growth 17.28%
EPS growth N/A
Profitability
72 /100
Strong Gross margin 75.33%
FCF margin 9.48%
Net margin 15.65%
Quality
52 /100
Average ROIC 7.70%
Asset turnover 0.50x
ROE 12.71%
Debt
91 /100
Low Debt/Equity 0.09x
Net debt/EBITDA -4.79x
Current ratio 3.59x
Stability
43 /100
Moderate Beta 0.15x
Profitable years 2
Rev. volatility 10.48%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o BRSYF
Online
Sector
Healthcare
Industry
Medical - Specialties
CEO
Hadar Levy
Employees
129
Headquarters
Jerusalem
Prihajajoči dogodki
10 NOV.
Earnings
Upcoming earnings report